An environmental and biological study of occupational exposure to cyclophosphamide in the pharmacy of a Japanese community hospital designated for the treatment of cancer

Manabu Tanimura, Kiyofumi Yamada, Shin Ichi Sugiura, Keiki Mori, Hiroaki Nagata, Kyoko Tadokoro, Tomohiro Miyake, Youko Hamaguchi, Paul Sessink, Toshitaka Nabeshima

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Cancer treatment in Japan is considered to be very progressive in the use of antineoplastic agents. Pharmacists are required to compound more antineoplastic preparations recently and thus are at risk for exposure to antineoplastic agents. In Japan, healthcare professionals have recognized the need for protection, but there have been few reports of environmental contamination or occupational exposure to antineoplastic agents. In the present study, urine samples over 24 hr from compounding pharmacists and wipe samples from the compounding room were collected to analyze levels of cyclophosphamide (CP). CP was detected in urine samples from all 4 pharmacists (mean = 165.3 ng/24 hr) and for all wipe samples of the compounding room. From the results of these tests, the standard operating procedure (SOP) of the pharmacy was revised as a protective measure. The tests were then repeated and CP was detected again in the urine of all 4 compounding pharmacists, though the mean CP level was reduced from 165.3 to 47.4 ng/24 hr after the revision of the SOP. Although there was no correlation between the amount of CP compounded and the CP levels in urine initially, the 2 values were significantly correlated after the revision of the SOP (R2 = 0.87).

Original languageEnglish
Pages (from-to)750-756
Number of pages7
JournalJournal of Health Science
Volume55
Issue number5
DOIs
Publication statusPublished - 01-10-2009

Fingerprint

Community Hospital
Occupational Exposure
Cyclophosphamide
Pharmacists
Antineoplastic Agents
Urine
Neoplasms
Japan
Therapeutics
Oncology
Environmental Exposure
Contamination
Delivery of Health Care

All Science Journal Classification (ASJC) codes

  • Toxicology
  • Health, Toxicology and Mutagenesis

Cite this

Tanimura, Manabu ; Yamada, Kiyofumi ; Sugiura, Shin Ichi ; Mori, Keiki ; Nagata, Hiroaki ; Tadokoro, Kyoko ; Miyake, Tomohiro ; Hamaguchi, Youko ; Sessink, Paul ; Nabeshima, Toshitaka. / An environmental and biological study of occupational exposure to cyclophosphamide in the pharmacy of a Japanese community hospital designated for the treatment of cancer. In: Journal of Health Science. 2009 ; Vol. 55, No. 5. pp. 750-756.
@article{be58aec84cb14475ade83276e729bbca,
title = "An environmental and biological study of occupational exposure to cyclophosphamide in the pharmacy of a Japanese community hospital designated for the treatment of cancer",
abstract = "Cancer treatment in Japan is considered to be very progressive in the use of antineoplastic agents. Pharmacists are required to compound more antineoplastic preparations recently and thus are at risk for exposure to antineoplastic agents. In Japan, healthcare professionals have recognized the need for protection, but there have been few reports of environmental contamination or occupational exposure to antineoplastic agents. In the present study, urine samples over 24 hr from compounding pharmacists and wipe samples from the compounding room were collected to analyze levels of cyclophosphamide (CP). CP was detected in urine samples from all 4 pharmacists (mean = 165.3 ng/24 hr) and for all wipe samples of the compounding room. From the results of these tests, the standard operating procedure (SOP) of the pharmacy was revised as a protective measure. The tests were then repeated and CP was detected again in the urine of all 4 compounding pharmacists, though the mean CP level was reduced from 165.3 to 47.4 ng/24 hr after the revision of the SOP. Although there was no correlation between the amount of CP compounded and the CP levels in urine initially, the 2 values were significantly correlated after the revision of the SOP (R2 = 0.87).",
author = "Manabu Tanimura and Kiyofumi Yamada and Sugiura, {Shin Ichi} and Keiki Mori and Hiroaki Nagata and Kyoko Tadokoro and Tomohiro Miyake and Youko Hamaguchi and Paul Sessink and Toshitaka Nabeshima",
year = "2009",
month = "10",
day = "1",
doi = "10.1248/jhs.55.750",
language = "English",
volume = "55",
pages = "750--756",
journal = "Journal of Health Science",
issn = "1344-9702",
publisher = "Pharmaceutical Society of Japan",
number = "5",

}

An environmental and biological study of occupational exposure to cyclophosphamide in the pharmacy of a Japanese community hospital designated for the treatment of cancer. / Tanimura, Manabu; Yamada, Kiyofumi; Sugiura, Shin Ichi; Mori, Keiki; Nagata, Hiroaki; Tadokoro, Kyoko; Miyake, Tomohiro; Hamaguchi, Youko; Sessink, Paul; Nabeshima, Toshitaka.

In: Journal of Health Science, Vol. 55, No. 5, 01.10.2009, p. 750-756.

Research output: Contribution to journalArticle

TY - JOUR

T1 - An environmental and biological study of occupational exposure to cyclophosphamide in the pharmacy of a Japanese community hospital designated for the treatment of cancer

AU - Tanimura, Manabu

AU - Yamada, Kiyofumi

AU - Sugiura, Shin Ichi

AU - Mori, Keiki

AU - Nagata, Hiroaki

AU - Tadokoro, Kyoko

AU - Miyake, Tomohiro

AU - Hamaguchi, Youko

AU - Sessink, Paul

AU - Nabeshima, Toshitaka

PY - 2009/10/1

Y1 - 2009/10/1

N2 - Cancer treatment in Japan is considered to be very progressive in the use of antineoplastic agents. Pharmacists are required to compound more antineoplastic preparations recently and thus are at risk for exposure to antineoplastic agents. In Japan, healthcare professionals have recognized the need for protection, but there have been few reports of environmental contamination or occupational exposure to antineoplastic agents. In the present study, urine samples over 24 hr from compounding pharmacists and wipe samples from the compounding room were collected to analyze levels of cyclophosphamide (CP). CP was detected in urine samples from all 4 pharmacists (mean = 165.3 ng/24 hr) and for all wipe samples of the compounding room. From the results of these tests, the standard operating procedure (SOP) of the pharmacy was revised as a protective measure. The tests were then repeated and CP was detected again in the urine of all 4 compounding pharmacists, though the mean CP level was reduced from 165.3 to 47.4 ng/24 hr after the revision of the SOP. Although there was no correlation between the amount of CP compounded and the CP levels in urine initially, the 2 values were significantly correlated after the revision of the SOP (R2 = 0.87).

AB - Cancer treatment in Japan is considered to be very progressive in the use of antineoplastic agents. Pharmacists are required to compound more antineoplastic preparations recently and thus are at risk for exposure to antineoplastic agents. In Japan, healthcare professionals have recognized the need for protection, but there have been few reports of environmental contamination or occupational exposure to antineoplastic agents. In the present study, urine samples over 24 hr from compounding pharmacists and wipe samples from the compounding room were collected to analyze levels of cyclophosphamide (CP). CP was detected in urine samples from all 4 pharmacists (mean = 165.3 ng/24 hr) and for all wipe samples of the compounding room. From the results of these tests, the standard operating procedure (SOP) of the pharmacy was revised as a protective measure. The tests were then repeated and CP was detected again in the urine of all 4 compounding pharmacists, though the mean CP level was reduced from 165.3 to 47.4 ng/24 hr after the revision of the SOP. Although there was no correlation between the amount of CP compounded and the CP levels in urine initially, the 2 values were significantly correlated after the revision of the SOP (R2 = 0.87).

UR - http://www.scopus.com/inward/record.url?scp=70350236730&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70350236730&partnerID=8YFLogxK

U2 - 10.1248/jhs.55.750

DO - 10.1248/jhs.55.750

M3 - Article

VL - 55

SP - 750

EP - 756

JO - Journal of Health Science

JF - Journal of Health Science

SN - 1344-9702

IS - 5

ER -